Zeerleder SS - Search Results

1

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.

Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Jäger U, et al. Among authors: zeerleder ss. Blood Rev. 2020 May;41:100648. doi: 10.1016/j.blre.2019.100648. Epub 2019 Dec 5. Blood Rev. 2020. PMID: 31839434 Review.

2

Lyse or not to lyse: Clinical significance of red blood cell autoantibodies.

Meulenbroek EM, Wouters D, Zeerleder SS. Meulenbroek EM, et al. Among authors: zeerleder ss. Blood Rev. 2015 Nov;29(6):369-76. doi: 10.1016/j.blre.2015.05.001. Epub 2015 May 8. Blood Rev. 2015. PMID: 26006097 Review.

3

Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies.

Meulenbroek EM, de Haas M, Brouwer C, Folman C, Zeerleder SS, Wouters D. Meulenbroek EM, et al. Among authors: zeerleder ss. Haematologica. 2015 Nov;100(11):1407-14. doi: 10.3324/haematol.2015.128991. Epub 2015 Sep 9. Haematologica. 2015. PMID: 26354757 Free PMC article.

4

Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Wouters D, Zeerleder S. Wouters D, et al. Haematologica. 2015 Nov;100(11):1388-95. doi: 10.3324/haematol.2015.128538. Haematologica. 2015. PMID: 26521297 Free PMC article. Review.

5

Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity.

Boshuizen M, van der Ploeg K, von Bonsdorff L, Biemond BJ, Zeerleder SS, van Bruggen R, Juffermans NP. Boshuizen M, et al. Among authors: zeerleder ss. Blood Rev. 2017 Nov;31(6):400-405. doi: 10.1016/j.blre.2017.07.005. Epub 2017 Jul 24. Blood Rev. 2017. PMID: 28755795 Review.

6

Consequences of dysregulated complement regulators on red blood cells.

Thielen AJF, Zeerleder S, Wouters D. Thielen AJF, et al. Blood Rev. 2018 Jul;32(4):280-288. doi: 10.1016/j.blre.2018.01.003. Epub 2018 Jan 31. Blood Rev. 2018. PMID: 29397262 Review.

7

It takes two to thrombosis: Hemolysis and complement.

Delvasto-Nuñez L, Jongerius I, Zeerleder S. Delvasto-Nuñez L, et al. Blood Rev. 2021 Nov;50:100834. doi: 10.1016/j.blre.2021.100834. Epub 2021 Apr 30. Blood Rev. 2021. PMID: 33985796 Free article. Review.

8

Thromboembolic complications in autoimmune hemolytic anemia: Retrospective study.

Schär DT, Daskalakis M, Mansouri B, Rovo A, Zeerleder S. Schär DT, et al. Eur J Haematol. 2022 Jan;108(1):45-51. doi: 10.1111/ejh.13710. Epub 2021 Oct 24. Eur J Haematol. 2022. PMID: 34551149 Free PMC article.

9

C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.

de Boer ECW, Jalink M, Delvasto-Nuñez L, Meulenbroek EM, Baas I, Janssen SR, Folman CC, Gelderman KA, Wouters D, Engel MD, de Haas M, Kersten MJ, Jongerius I, Zeerleder S, Vos JMI. de Boer ECW, et al. Blood Adv. 2023 Jul 11;7(13):3128-3139. doi: 10.1182/bloodadvances.2022009402. Blood Adv. 2023. PMID: 36920779 Free PMC article. Clinical Trial.

10

Aleukemic variant of mast cell leukemia.

Zeerleder S, van Oers M. Zeerleder S, et al. Blood. 2012 Mar 1;119(9):1961. doi: 10.1182/blood-2011-04-344952. Blood. 2012. PMID: 22482127 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters